Granisetron Transdermal Patch and Clomipramine: Interaction Details

Brand names
Clomipramine
Anafranil
Granisetron Transdermal Patch
SancusoSustolGranisol
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Granisetron Transdermal Patch and Clomipramine interaction:

Share

Share this interaction

Granisetron Transdermal Patch

Brand names
  • Sancuso
  • Sustol
  • Granisol

What Happens When You Take Granisetron Transdermal Patch With Clomipramine

What can happen when they are taken together (rated Major)

Increased risk of and

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

When granisetron is taken together with a drug that is both and QT-prolonging, the risk of serotonin syndrome1 and of QT-interval prolongation2 may rise. Cases of serotonin syndrome have been described when 5-hydroxytryptamine-3 were used alongside serotonergic agents, mostly in infusion centers or post-anesthesia care units.

Should be necessary, watch for signs of serotonin syndrome. If such symptoms appear, granisetron should be stopped and supportive therapy started.1 In addition, giving granisetron with other agents that prolong the can produce effects on the QT-interval, so caution is advised.2

The Granisetron Transdermal Patch and Clomipramine Interaction, Explained

Clomipramine (Anafranil) is an antidepressant often used for OCD or depression. Granisetron patches (Sancuso) help prevent nausea from chemotherapy. Both can affect , a brain chemical, and both can affect the heart's electrical rhythm (the ). Taking them together may add up those effects.

The evidence here is mostly theoretical, but it is rated major, so it deserves attention. Signs to watch for include agitation, fast heartbeat, sweating, shaking, muscle twitching, diarrhea, fever, dizziness, or fainting. Keep taking both as prescribed, and call your pharmacist or doctor right away if you notice these. Your care team can manage this by monitoring you closely.

Mechanism: activity (clomipramine, a potent reuptake TCA, plus the 5-HT3 granisetron) and additive (). Neither effect relies on a -mediated change in exposure here.

  • Risk: and QTc prolongation; reports with 5-HT3 antagonists plus serotonergic drugs occurred mainly in infusion centers and post-anesthesia care units.
  • Evidence: Theoretical; onset unspecified; severity major.
  • Management: If is required, monitor for serotonin syndrome (mental status, neuromuscular, autonomic signs). Discontinue granisetron and give supportive care if it occurs. Use caution given additive QT effects; consider and electrolyte (K, Mg) monitoring, particularly with other risk factors.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Granisetron Transdermal Patch and Clomipramine Interact

The likely mechanism

; additive

In short: Granisetron transdermal patch and clomipramine both raise serotonin activity, and lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Granisetron Transdermal Patch and Clomipramine Interaction

Your care team may choose to use both medicines together if needed, and may monitor you more closely while you do.

  • Keep taking both as prescribed unless your prescriber tells you otherwise.
  • Learn the warning signs of : agitation, sweating, shivering, muscle twitching or stiffness, fast heartbeat, diarrhea, fever.
  • Report fainting, dizziness, or a racing or irregular heartbeat right away.
  • If serotonin syndrome symptoms occur, your team may stop the granisetron and provide supportive care.
  • Tell your pharmacist and doctor about all other medicines you take, since others can also affect heart rhythm.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Granisetron Transdermal Patch or Clomipramine need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Granisetron Transdermal Patch and Clomipramine: Common Questions

How serious is the Granisetron Transdermal Patch and Clomipramine interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Granisetron Transdermal Patch and Clomipramine interaction managed?

Your care team may choose to use both medicines together if needed, and may monitor you more closely while you do. Keep taking both as prescribed unless your prescriber tells you otherwise. Learn the warning signs of : agitation, sweating, shivering, muscle twitching or stiffness, fast heartbeat, diarrhea, fever. Report fainting, dizziness, or a racing or irregular heartbeat righ… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Granisetron Transdermal Patch and Clomipramine Interaction

Ask in your own words about taking Granisetron Transdermal Patch and Clomipramine together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: SANCUSO(R) transdermal system, granisetron transdermal system. Kyowa Kirin Inc (per FDA), Bedminster, NJ, 2020. DailyMed
  2. Product Information: KYTRIL(R) IV injection, granisetron HCl IV injection. Genentech USA, Inc, South San Francisco, CA, 2011.
Was this write-up helpful?

Other Serious Interactions of Granisetron Transdermal Patch and Clomipramine

Also serious with Clomipramine

Also serious with Granisetron Transdermal Patch

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Clomipramine

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.